Production (Stage)
BioAtla, Inc.
BCAB
$0.3896
$0.00832.18%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -34.46% | -48.62% | -42.27% | -47.68% | -13.11% |
| Gross Profit | 34.46% | 48.62% | 81.00% | 47.68% | 13.11% |
| SG&A Expenses | -6.17% | -21.63% | -11.25% | -7.48% | -22.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -27.98% | -43.08% | -36.41% | -40.94% | -15.46% |
| Operating Income | 27.98% | 43.08% | 67.82% | 40.94% | 15.46% |
| Income Before Tax | 34.00% | 44.72% | 68.23% | 41.06% | 15.39% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 34.00% | 44.72% | 68.23% | 41.06% | 15.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.00% | 44.72% | 68.23% | 41.06% | 15.39% |
| EBIT | 27.98% | 43.08% | 67.82% | 40.94% | 15.46% |
| EBITDA | 28.02% | 43.14% | 68.22% | 41.09% | 15.43% |
| EPS Basic | 45.53% | 46.57% | 68.57% | 41.69% | 16.29% |
| Normalized Basic EPS | 45.53% | 46.59% | 68.56% | 41.67% | 16.27% |
| EPS Diluted | 45.53% | 46.57% | 68.57% | 41.69% | 16.29% |
| Normalized Diluted EPS | 45.53% | 46.59% | 68.56% | 41.67% | 16.27% |
| Average Basic Shares Outstanding | 21.13% | 3.47% | 1.05% | 1.07% | 1.07% |
| Average Diluted Shares Outstanding | 21.13% | 3.47% | 1.05% | 1.07% | 1.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |